Duopharma Biotech Berhad (KLSE:DPHARMA)

Duopharma Biotech Berhad Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,327	1,202	1,212	1,533	1,582	2,386
Market Cap Growth	6.35%	-0.79%	-20.94%	-3.10%	-33.70%	145.56%
Enterprise Value	1,567	1,469	1,522	1,819	1,881	2,521
Last Close Price	1.38	1.22	1.20	1.50	1.55	2.28
PE Ratio	17.34	19.19	23.02	21.87	24.09	40.72
Forward PE	14.20	14.74	14.77	15.91	20.97	34.68
PS Ratio	1.50	1.48	1.72	2.20	2.48	4.19
PB Ratio	1.80	1.70	1.76	2.34	2.54	3.71
P/TBV Ratio	1.92	1.71	1.78	2.35	2.56	3.73
P/FCF Ratio	13.37	20.12	76.43	301.61	-	156.62
P/OCF Ratio	9.96	14.43	24.84	21.82	36.62	33.45
EV/Sales Ratio	1.77	1.81	2.16	2.61	2.94	4.42
EV/EBITDA Ratio	9.91	10.70	13.35	14.80	16.36	23.80
EV/EBIT Ratio	13.33	14.66	19.34	19.57	21.19	30.79
EV/FCF Ratio	15.78	24.59	95.99	357.77	-	165.43
Debt / Equity Ratio	0.67	0.73	0.80	0.66	0.65	0.47
Debt / EBITDA Ratio	3.13	3.66	4.67	3.41	3.41	2.77
Debt / FCF Ratio	4.99	8.63	34.61	84.91	-	19.91
Asset Turnover	0.64	0.60	0.55	0.58	0.57	0.58
Inventory Turnover	2.31	2.08	1.83	1.82	2.06	2.28
Quick Ratio	2.65	2.65	2.59	1.13	1.18	1.95
Current Ratio	3.98	4.08	4.06	2.05	2.15	3.06
Return on Equity (ROE)	10.70%	8.97%	7.84%	10.96%	10.36%	9.99%
Return on Assets (ROA)	5.32%	4.60%	3.83%	4.87%	4.99%	5.17%
Return on Capital (ROIC)	6.00%	5.09%	4.24%	5.49%	5.62%	5.87%
Return on Capital Employed (ROCE)	9.60%	8.40%	6.70%	9.70%	9.50%	9.00%
Earnings Yield	5.76%	5.21%	4.34%	4.57%	4.15%	2.46%
FCF Yield	7.48%	4.97%	1.31%	0.33%	-4.18%	0.64%
Dividend Yield	2.17%	2.47%	1.92%	1.53%	1.41%	2.14%
Payout Ratio	37.71%	42.99%	16.81%	11.70%	68.45%	12.34%
Buyback Yield / Dilution	0.06%	-0.36%	-1.08%	-2.15%	-0.02%	-3.86%
Total Shareholder Return	2.23%	2.11%	0.85%	-0.62%	1.39%	-1.72%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.